Clinical Trials

  • Long-Acting ART in Non-Adherent Participants

    Principal Investigator:

    Michael T Yin, MD
    We are doing a research study to find out if Long-Acting Injectable anti-HIV medications will be more successful than standard pills for people who have a hard time taking their HIV pills. If you are over the age of 18 years old, have been prescribed HIV medications but have had difficulty getting undetectable viral load (when the levels of virus in the bloodstream are so low that they can't be measured), you may be eligible. You may receive up to $1100 for the first 5 months of participation. Contact us to find out more about this study.

  • Oral Health and Bone Loss in Women and Men

    Principal Investigator:

    Michael T Yin, MD
    The study is exploring the impact of gender, age, HIV infection, and menopausal status on dental health. The study is open to men and women, ages 35-70.

  • Oral Health and Bone Loss in Women and Men (Healthy Volunteers)

    Principal Investigator:

    Michael T Yin, MD
    The study is exploring the impact of gender, age, HIV infection, and menopausal status on dental health. The study is open to men and women, ages 35-70.

  • Respiratory Syncytial Virus (RSV) Vaccine Study

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    The main purpose of this study is to evaluate a Respiratory Syncytial Virus vaccine (RSVpreF for short). Respiratory Syncytial Virus, called RSV, is a common type of virus that is a major cause of respiratory infection in all ages, and can result in severe illness in those with health conditions that put them at increased risk of severe RSV and complications. We are doing a study to test the safety of the RSVpreF vaccine, and how well it is tolerated. The study will also test how a person's immune system responds to the vaccines and how much antibody is made after the vaccine. Approximately...

  • Respiratory Syncytial Virus (RSV) Vaccine Study (Healthy Volunteers)

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    The main purpose of this research project is to study a vaccine made to prevent disease due to infection with the Respiratory Syncytial Virus (RSV). We want to find out how the body responds to the RSV vaccine, as well as look at the safety of the vaccine. RSV is a common virus that can cause infections of the air passages. Adults 60 years of age and older have a higher risk of getting severe RSV disease than younger adults. However, adults below 60 years of age with long-term (chronic) health conditions may also have a higher risk of severe RSV disease. These health conditions may include...

  • Respiratory Syncytial Virus (RSV) Vaccine Study for Lung or Kidney Transplant Recipients

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    The main purpose of this research project is to study a vaccine made to prevent disease due to infection with the Respiratory Syncytial Virus (RSV). We want to find out how the body responds to the RSV vaccine, as well as look at the safety of the vaccine. RSV is a common virus that can cause infections of the air passages. Adults 60 years of age and older have a higher risk of getting severe RSV disease than younger adults. However, adults below 60 years of age with long-term (chronic) health conditions may also have a higher risk of severe RSV disease. These health conditions may include...

  • Respiratory Syncytial Virus (RSV) Vaccine Study for Lung or Kidney Transplant Recipients

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    The main purpose of this research project is to study a vaccine made to prevent disease due to infection with the Respiratory Syncytial Virus (RSV). We want to find out how the body responds to the RSV vaccine, as well as look at the safety of the vaccine. RSV is a common virus that can cause infections of the air passages. Adults 60 years of age and older have a higher risk of getting severe RSV disease than younger adults. However, adults below 60 years of age with long-term (chronic) health conditions may also have a higher risk of severe RSV disease. These health conditions may include...

  • Screening for COVID-19 Vaccine, Prevention and Treatment Research Studies

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    We are looking for individuals over 18 years old who are interested in learning more about COVID-19 prevention research studies. We will ask you to complete a brief questionnaire to find out if you may be eligible for one of our studies. We can then schedule a phone call, teleconference, or in-person education visit so you can learn about the research we do and decide if you want to participate in one of our studies. Your responses to this questionnaire will be kept strictly confidential.

  • Stick2PrEP: Women/Trans/Non-Binary Individuals

    Principal Investigator:

    Magdalena E Sobieszczyk, MD
    Do you identify as a woman or transgender person, or do you have a non-binary gender identity? Has a medical provider ever diagnosed you with a sexually transmitted infection or recommended PrEP/another HIV prevention method? We are conducting a study to understand attitudes and preferences regarding HIV prevention methods among people who do not have HIV. The study involves taking online surveys. Some surveys are compensated. Please reach out if you are interested in hearing more about the study.

  • Study of Learning Mindfulness Meditation to Improve Symptoms in Patients with Long COVID

    Principal Investigator:

    Deborah A. Theodore, MD
    This is a study for people with symptoms of long COVID. We are looking for people over the age of 18 who are interested in participating in a study to understand whether a mindfulness meditation intervention can help improve symptoms of long COVID. Study participation lasts 12 weeks and is fully remote.

Pages